Abstract:The title compound, C14H14BrNO4, contains a tricyclic ring system including three contiguous stereocenters all of which exhibit an R configuration. The cyclo-hexa-none ring adopts a chair conformation. The central oxane ring assumes a strained envelope conformation, with five of the ring atoms being nearly coplanar with the bromo-phenyl group and with the C atom adjacent to the O atom and fused with the cyclo-hexa-none ring as the flap. In the crystal, mol-ecules are linked into a three-dimensional network by C-H⋯O inter-actions.

4′-Fluoro-2′-nitroacetanilide

N-(2,4-Dinitrophenyl)dehydroabietylamine

2,2′-Diamino-4,4′-bi-1,3-thiazol-3,3′-diium Bis(2,2′-Diamino-4,4′-bi-1,3-thiazol-3-ium) Tetrakis(2-Nitrobenzoate)

<i>N</i>,<i>N</i>′-Bis(3,4-dimethoxybenzylidene)ethylenediamine

2-(4-Fluorophenoxy)-n-methylacetamide

N,N′-Bis(2-nitrobenzylidene)ethylenediamine

N-Benzyl-2-(2-bromophenyl)-2-(2-nitrophenoxy)acetamide

2-(4-Fluoro-phen-oxy)-N-methyl-acetamide

(4Ar,9r,9ar)-7-bromo-9-nitromethyl-2,3,4,4a,9,9a-hexahydro-1h-xanthen-1- One

4-(2-Chloro-4-nitrophenoxy)-n-[2-(4,6-dimethoxypyrimidin-2-yloxy)benzyl]aniline

N-Cyclohexyl-2-oxo-2-phenylacetamide

4′-Chloro-3′,5′-dimethoxyacetanilide

2-(2-Chloro-phen-yl)-2-oxo-N-phenyl-acetamide.

4-Fluoro-2-(phenyl-amino)-benzoic acid

4-Chloro-n-(4-cyano-2-nitrophenyl)-3-nitrobenzamide

2-(2-Nitroanilino)benzoic Acid

4-(3,4-Dimethoxyphenyl)-2-oxo-n,3-bis(3,4,5-trimethoxyphenyl)-2,3-dihydro-1h-imidazoline-1-carboxamide

2-Cyano-N,N-dimethylacetamide

(E)-Ethyl 3-(2-Fluoroanilino)-2-(4-methoxyphenyl)acrylate

4,4-Diacetylheptanedinitrile